top of page

Two Blood Draws, and Something to Return To After Discharge

Nov 6
2 min read

A client who leaves residential treatment feeling steady will still have a hard day at home. When that day comes, the feeling at discharge is the only evidence the client has that anything changed, and a bad afternoon can erase it.

A scientist in a white coat seated at a microscope in a bright laboratory.

Discharge data gives that client something more durable to return to.

Two draws, one record

Every Neurova Academy client package includes two blood kits from iXpressGenes, a CLIA-certified and CAP-accredited laboratory. The first is drawn at admission and the second before discharge. The kit is self-collected from the upper arm, so the center needs no phlebotomist on staff.

The iXpressGenes CoreSignals Panel reads 22 markers of RNA gene expression from whole blood, and it is designed to track inflammatory and immune signals associated with stress and recovery. It is not used to diagnose any condition. The same signals move with sleep, illness, exertion and diet, so the panel serves as a record of change over a stay. Tying a reading to any one cause takes more than the panel can show. Our measurement page lays out the panel and its limits in full.

Why a record matters after discharge

Alumni teams already know the pattern. Engagement drops in the weeks after a client goes home, and a check-in call has little to anchor it.

A pair of results gives that call a starting point. The client and the alumni team can look at the same record together, and the client goes home with the program itself on a headset of their own, so the work from treatment continues.

A note for clinicians

These results sit beside the instruments a clinical team already uses. They add a second kind of record and leave clinical judgment where it belongs.

Next step

Centers that want to see how the two draws fit an admission and discharge schedule can book a call with our team.


Neurova Academy is a general wellness and cognitive training program. It is not a medical device and is not offered to diagnose, treat, cure, or mitigate any disease or condition, including concussion, traumatic brain injury, or CTE. Outcomes described reflect observational pilot findings and individual experience, and are not a prediction of results for anyone else. Individual results vary. Laboratory testing provided by iXpressGenes, a CLIA-certified, CAP-accredited laboratory. References to news reporting, government publications, and published research are for commentary only and do not imply endorsement of Neurova Labs by any federal entity or research institution.

Media contact: Nathaniel Free, chief communications officer, nathaniel.free@neurovalabs.com

Comments


bottom of page